Filter
562
Filtered Results: 562
Text search:
pharmacovigilance
Featured
Recommendations
65
New Publications
165
Language
Document type
No document type
268
Guidelines
115
Studies & Reports
80
Strategic & Response Plan
29
Manuals
28
Fact sheets
16
Resource Platforms
8
Training Material
7
Situation Updates
4
Online Courses
4
Infographics
2
Videos
1
Countries / Regions
Kenya
26
Congo, Democratic Republic of
17
South Africa
17
Ghana
16
India
16
Nigeria
15
Global
14
Western and Central Europe
14
Uganda
14
Senegal
12
Eastern Europe
12
Rwanda
11
Ethiopia
11
Nepal
10
Latin America and the Carribbean
10
Namibia
10
West and Central Africa
9
Sierra Leone
8
Burkina Faso
8
Malawi
8
Tanzania
8
East and Southern Africa
8
Zambia
8
Madagascar
8
Africa
7
Benin
6
Haiti
6
South–East Asia Region
6
Philippines
5
Cambodia
5
Bangladesh
5
Russia
5
Botswana
5
Liberia
5
Middle East and North Africa
4
Ukraine
3
Lesotho
3
Zimbabwe
3
Mozambique
3
Eastern Europe and Central Asia
3
Chile
2
Cameroon
2
Syria
2
Morocco
2
Asia
2
Paraguay
2
Lebanon
2
Brazil
2
Sudan
2
Chad
2
Libya
2
Indonesia
2
Myanmar / Burma
2
Eswatini/ Swaziland
2
Pakistan
2
Thailand
1
Gambia
1
Laos
1
Afghanistan
1
Burundi
1
Guinea
1
Jordan
1
Western Pacific Region
1
France
1
Maldives
1
Southern Africa
1
Argentina
1
Sri Lanka
1
Yemen
1
Georgia
1
Mali
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
281
Clinical Guidelines
63
Public Health
18
Pharmacy & Technologies
10
Capacity Building
8
Women & Child Health
8
Key Resources
7
Toolboxes
Pharmacy
73
COVID-19
62
TB
55
AMR
46
NTDs
27
HIV
23
Rapid Response
6
Ebola & Marburg
6
Caregiver
5
Planetary Health
5
NCDs
4
Refugee
3
Specific Hazards
2
Global Health Education
2
Cholera
1
Conflict
1
Zika
1
Polio
1
International Journal of Basic & Clinical Pharmacology 5(6):2290-2294
DOI: 10.18203/2319-2003.ijbcp20164081
Module 5
Monitoring and Evaluation
October 2018
Module 5: Monitoring and evaluation. This module is for people responsible for monitoring PrEP programmes at the national and site levels. It provides information on how to monitor PrEP for safety and effectiveness, suggesting core and additiona...
The World Health Organization's fourth Country Cooperation Strategy 2022-2026 is an outcome of a consultative process with inputs from the Ministry of Health, various agencies in the health sector, and other relevant stakeholders. It has been developed to provide strategic direction and support towa...
Copenhagen, Denmark, 7–8 March 2017. Meeting report
Rwanda Guidelines for variation to registered pharmaceutical products.
Preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups
recommended
Treating children infected with intestinal worms is one of the simplest and most cost–effective ways to improve their health.
The recommendations are intended for a wide audience, including policy-makers and their expert advisers as well as technical and programme staff at government institution...
This report presents an overview of the transition process in Azerbaijan, some sustainability aspects and challenges stemming from donor withdrawal from TB-related activities, along with recommendations on how to overcome transition-related difficulties and ensure sustainability.
Evaluation report
April 2013
Evaluation report
This report is part of the overall Ukrainian National AIDS programme evaluation conducted
in September 2012
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
The "Primary Healthcare Standard Treatment Guidelines and Essential Medicines List" by the South African National Department of Health provides evidence-based guidelines for diagnosing and managing common medical conditions at the primary healthcare level. This document includes treatment protocols ...
Myanmar, as a country going through rapid socio-political transition and institutional development also suffers with a high burden of infectious disease. An ongoing challenge has been to effectively reach its 51 million population, most of whom battle tuberculosis, acute respiratory infections, diar...
